Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment

Due to the complex mechanism and limited treatments available for pulmonary fibrosis, the development of targeted drugs or inhibitors based on their molecular mechanisms remains an important strategy for prevention and treatment. In this paper, the downstream signaling pathways mediated by VEGFR and...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Ya-Li, Li, Yan, Zhou, Wen, Wang, Si-Yu, Liu, Yong-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482219/
https://www.ncbi.nlm.nih.gov/pubmed/37680863
http://dx.doi.org/10.2147/DDDT.S415453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482219/
https://www.ncbi.nlm.nih.gov/pubmed/37680863
http://dx.doi.org/10.2147/DDDT.S415453

Ejemplares similares